Trademark: 79315746
Word
ANAVEON
Status Date
Tuesday, June 28, 2022
Registration Number
6770173
Registration Date
Tuesday, June 28, 2022
Filing Date
Tuesday, May 11, 2021
Published for Opposition
Tuesday, April 12, 2022
5 Pharmaceutical preparations for treating cancer or autoimmune diseases
42 Research and development in the pharmaceutical and biotechnology fields; industrial research in the field of pharmaceuticals; research and development services in the field of immunology; research and development for the pharmaceutical industry; scientific research services for medical purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research, testing and analysis services; scientific and medical research and development; provision of information relating to medical and scientific research in the field of pharmaceutical products; laboratory research and analysis services
Oct 13, 2022
Final Disposition Notice Sent To Ib
Oct 13, 2022
Final Disposition Processed
Sep 28, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jun 28, 2022
Notice Of Registration Confirmation Emailed
Jun 28, 2022
Registered-Principal Register
Apr 12, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2022
Published For Opposition
Mar 23, 2022
Notification Of Notice Of Publication E-Mailed
Mar 10, 2022
Approved For Pub - Principal Register
Mar 7, 2022
Refusal Processed By Ib
Mar 7, 2022
Teas/Email Correspondence Entered
Mar 7, 2022
Correspondence Received In Law Office
Mar 7, 2022
Teas Response To Office Action Received
Feb 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Feb 15, 2022
Refusal Processed By Mpu
Jan 26, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 25, 2022
Non-Final Action Written
Jan 19, 2022
Assigned To Examiner
Jul 24, 2021
Application Filing Receipt Mailed
Jul 20, 2021
New Application Office Supplied Data Entered In Tram
Jul 15, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24